Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
Yuzhuo Zhang, Jiangpeng Lin, Zhixuan You, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5643-5643
Open Access | Times Cited: 20
Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis
Cristina Bezzio, Marta Vernero, Davide Giuseppe Ribaldone, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2197-2197
Open Access | Times Cited: 18
Exploring the association between rheumatoid arthritis and non-small cell lung cancer risk: a transcriptomic and drug target-based analysis
Lyubo Wang, Yan Dong, Qingcheng Yang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025
Mário Dinis‐Ribeiro, Diogo Libânio, Hugo Uchima, et al.
Endoscopy (2025)
Closed Access
Inflammatory Pathways to Carcinogenesis: Deciphering the Rheumatoid Arthritis–Lung Cancer Connection
Boushra Abou Hjeily, Briana Candace Nevaneeth, Włodzimierz Samborski, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1330-1330
Open Access
Jugando con la balanza: el desafío de las patologías con tratamientos opuestos
Karen Vergara, Andrés Giglio Jimenez
Revista Médica Clínica Las Condes (2025) Vol. 36, Iss. 2, pp. 126-127
Open Access
Inflammatory Cytokines in Rheumatoid Arthritis: Diagnostic Challenges, Pathogenic Mechanisms and their Role in Depression and Management
Ayushi Sharma, Anjana Goel
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 27, pp. 2535-2551
Closed Access | Times Cited: 7
Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study
Shunsuke Mori, Mizue Hasegawa, Fumikazu Sakai, et al.
Modern Rheumatology (2024)
Open Access | Times Cited: 2
Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook
Koshiro Sonomoto, Yoshiya Tanaka
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1325-1342
Closed Access | Times Cited: 5
Construction of shared gene signature between rheumatoid arthritis and lung adenocarcinoma helps to predict the prognosis and tumor microenvironment of the LUAD patients
Liping Shi, Houwen Zou, Jian Yi
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 1
Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database
Wan Xiong, Jianping Li, Lin Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Co-Occurrence of Rheumatoid Arthritis and Lung Cancer—Coincidence or Not?
Ioana Munteanu, Constantin Gheorghevici, Catalin Constantin Coca, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2089-2089
Open Access
Page 1

Scroll to top